Chronic Migraineurs Form Carboxyhemefibrinogen and Iron-Bound Fibrinogen.
Publication/Presentation Date
1-1-2015
Abstract
Chronic migraine (CM) is a disabling painful condition that is associated with dementia and thrombotic disease. It has been proposed that carbon monoxide (CO) and iron may play a role in CM, and CO and iron are products of the heme oxygenase system which is widespread within the brain. Further, CO and iron enhance plasmatic coagulation in part via a fibrinogen-dependent mechanism. Thus, our goal was to determine whether patients with CM had experienced carboxyhemefibrinogen formation, iron bound fibrinogen formation and plasmatic hypercoagulability. Nonsmokers with CM were recruited after informed, written consent. Blood was collected, anticoagulated with sodium citrate, and then centrifuged with plasma stored at -80ºC. Carboxyhemefibrinogen formation, iron bound fibrinogen formation and coagulation kinetics were determined via thrombelastographic methods. Patient results were compared with laboratory values generated from normal control plasmas. Incidence (95% confidence intervals) of the various parameters was determined using the Clopper-Pearson method. Twenty-six CM patients (24 female) were recruited; they were 46±12 years old. With regard to fibrinogen modification, 88.5% (69.8%-97.6%) of CM patients had formation of carboxyhemefibrinogen, iron bound fibrinogen, or both. With regard to coagulation, 42.3% (23.4%-63.1%) of patients had abnormally decreased time to clot initiation, 80.8% (60.6%-93.4%) had abnormally large velocity of clot formation, and 46.2% (26.6%-66.7%) had abnormally strong clot strength. Patients with CM have a large incidence of carboxyhemefibrinogen and iron bound fibrinogen formation and hypercoagulability. Confirmatory and potential therapeutic clinical trials targeting CO and iron modified hypercoagulation as a source of pain and vascular disease in CM patients are indicated.
Volume
14
Issue
8
First Page
1079
Last Page
1085
ISSN
1996-3181
Published In/Presented At
Nielsen, V. G., Kulin, W., LaWall, J. S., MacFarland, F. N., Chen, A., Hadley, H. A., DaDeppo, A. J., Steinbrenner, E. B., & Matika, R. W. (2015). Chronic Migraineurs Form Carboxyhemefibrinogen and Iron-Bound Fibrinogen. CNS & neurological disorders drug targets, 14(8), 1079–1085. https://doi.org/10.2174/1871527314666150821110836
Disciplines
Medicine and Health Sciences
PubMedID
26295816
Department(s)
Department of Medicine
Document Type
Article